Share Twitter LinkedIn Facebook Email Katja Weisel, MD Head of the Myeloma Center, University of Tubingen, discusses Current Maintenance Regimens In MM. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read